These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
968 related articles for article (PubMed ID: 25941994)
1. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994 [TBL] [Abstract][Full Text] [Related]
2. BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo. Shao Q; Kannan A; Lin Z; Stack BC; Suen JY; Gao L Cancer Res; 2014 Dec; 74(23):7090-102. PubMed ID: 25277525 [TBL] [Abstract][Full Text] [Related]
3. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262 [TBL] [Abstract][Full Text] [Related]
4. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma. Xiang T; Bai JY; She C; Yu DJ; Zhou XZ; Zhao TL Cell Signal; 2018 Jan; 42():106-113. PubMed ID: 29050985 [TBL] [Abstract][Full Text] [Related]
5. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression. Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167 [TBL] [Abstract][Full Text] [Related]
6. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1. Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485 [TBL] [Abstract][Full Text] [Related]
8. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4. Gen Y; Muramatsu T; Inoue J; Inazawa J Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856 [TBL] [Abstract][Full Text] [Related]
9. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states. Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437 [TBL] [Abstract][Full Text] [Related]
11. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer. Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511 [TBL] [Abstract][Full Text] [Related]
12. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC. Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984 [TBL] [Abstract][Full Text] [Related]
13. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells. Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM Mol Cancer Ther; 2016 Jun; 15(6):1217-26. PubMed ID: 26983878 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517 [TBL] [Abstract][Full Text] [Related]
15. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms. Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731 [TBL] [Abstract][Full Text] [Related]
19. GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. Kumar K; Raza SS; Knab LM; Chow CR; Kwok B; Bentrem DJ; Popovic R; Ebine K; Licht JD; Munshi HG Sci Rep; 2015 Mar; 5():9489. PubMed ID: 25807524 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression. Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]